NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / DRDO's anti-coronavirus drug cleared for emergency use by DCGI
    DRDO's anti-coronavirus drug cleared for emergency use by DCGI
    India

    DRDO's anti-coronavirus drug cleared for emergency use by DCGI

    Written by Sagar
    May 08, 2021 | 05:45 pm 3 min read
    DRDO's anti-coronavirus drug cleared for emergency use by DCGI

    The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-coronavirus drug developed by a laboratory of the Defence Research and Development Organisation (DRDO) to treat moderate to severe patients, reports say. The drug can help save precious lives even as a dreadful second wave of the coronavirus continues to kill thousands every day. Here are more details on this.

    Drug comes in powder form, can be consumed orally

    The Institute of Nuclear Medicine and Allied Sciences (INMAS), the DRDO lab, along with the Hyderabad-based Dr. Reddy's Laboratories, has developed the anti-coronavirus therapeutic application of the drug 2-Deoxy-D-Glucose, also called 2-DG. The medicine comes in powder form in a sachet and can be consumed orally by dissolving it in water, the government has said in a release.

    It helps in faster recovery of patients, says government

    The results of clinical trials for the drug show that a molecule present in it helps in faster recovery of hospitalized coronavirus patients and also reduces their dependence on supplemental oxygen. It accumulates in the infected cells and stops the fatal virus from multiplying. In fact, a high percentage of patients treated with the drug tested negative for coronavirus in RT-PCR tests.

    Work on the drug was started early last year

    Scientists at INMAS-DRDO had started experimenting with this drug early last year. In the second round of trials, conducted on 110 patients, the drug was found to be safe for use in COVID-19 patients and showed significant improvement in their recovery process. Thereafter, phase three trials were conducted on 220 patients from last December to March 2021 at 27 coronavirus hospitals in several states.

    The COVID-19 crisis in India

    India is facing an unprecedented second wave of the coronavirus pandemic, reporting lakhs of infections and hundreds of deaths for the past few weeks. Further, the country's handling of the new wave has been marred by acute shortages of necessary medical equipment such as medical oxygen, hospital beds, ventilators, and drugs. Several friendly nations have rushed essential medical supplies to India in recent days.

    India reports 4 lakh cases for third straight day

    In the last 24 hours, India reported over four lakh new cases for the third straight day. More than 4,000 deaths linked to the coronavirus were also registered for the first time during the same period. India's active caseload has now crossed 37 lakh. The second wave peak is expected in a few days, however, experts have already warned of a possible third wave.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    India
    Defence Research and Development Organisation (DRDO)
    Drugs Controller General of India
    COVID-19

    India

    Hindu woman in Pakistan cracks prestigious CSS examination Pakistan News
    Coronavirus: India registers deadliest day, over 4 lakh new cases Vaccine
    Seema qualifies for Tokyo Olympics, Sumit Malik settles for silver Olympics
    Doctor arrested for charging Rs. 1.40L for transporting COVID-19 patient COVID-19

    Defence Research and Development Organisation (DRDO)

    DRDO to set up 500 oxygen plants within three months Rajnath Singh
    Aero India takes off on February 3 amidst COVID-19 Make in India
    Centre's 12-point action plan to fight COVID-19 in Delhi: Details Arvind Kejriwal
    BrahMos missile successfully test-fired at nearly 3X speed of sound Indian Army

    Drugs Controller General of India

    Expert panel recommended against granting EUA to Pfizer's vaccine: Officials Pfizer
    Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial Central Drugs Standard Control Organization (CDSCO)
    Days after participating in vaccine trial, man dies in Bhopal Madhya Pradesh
    Global leaders hail India's scientific innovation to combat COVID-19 India

    COVID-19

    Punjab: Farmers take out protest marches against weekend lockdown Punjab
    PM dials 4 Chief Ministers to discuss the COVID-19 situation Narendra Modi
    Prasidh Krishna tests positive for COVID-19 Kolkata Knight Riders (KKR)
    Twenty-one die allegedly after burying man without following COVID-19 protocol Rajasthan
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023